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Maternal smoking during pregnancy is associated with increased substance abuse in off-
spring. Preclinical research shows that in utero exposure to nicotine, the primary psychoac-
tive compound in tobacco smoke, influences the neurodevelopment of reward systems
and alters motivated behavior in offspring.The present study determined if prenatal nicotine
(PN) exposure altered the sensitivity to the reinforcing and aversive effects of methamphet-
amine (METH) in offspring using a low dose, intravenous (IV) exposure method. Pregnant
dams were administered nicotine (0.05 mg/kg/injection) or prenatal saline (PS) 3×/day on
gestational days 8–21, and adult offspring were tested using METH self-administration
(experiment 1) or METH-induced conditioned taste aversion (CTA; experiment 2) pro-
cedures. For METH self-administration, animals were trained to respond for IV METH
(0.05 mg/kg/infusion; fixed-ratio 3) and they were tested on varying doses of the reinforcer
(0.0005–1.0 mg/kg/infusion). For METH CTA, rats received three saccharin and METH pair-
ings (0, 0.3, or 0.5 mg/kg, sc) followed by 14 daily extinction trials. Experiment 1: PN and
PS animals exhibited inverted U-shaped dose-response curves; however, the PN animal’s
curve was shifted to the left, suggesting PN animals were more sensitive to the reinforcing
effects of METH. Experiment 2: METH CTA was acquired in a dose-dependent manner and
the factor of PN exposure was not related to the acquisition or extinction of METH-induced
CTA. There were no sex differences in either experiment. These results indicate that IV
PN-exposed adult offspring exhibited increased sensitivity to IV METH. This suggests that
PN exposure, via maternal smoking, will alter the reinforcing effects of METH during later
stages of development, and furthermore, will influence substance use vulnerability in adult
human offspring.
Keywords: maternal smoking, prenatal nicotine, intravenous, methamphetamine, self-administration, conditioned
taste aversion
INTRODUCTION
Maternal smoking during pregnancy imparts multiple health risks
on the fetus (Castles et al., 1999; Ernst et al., 2001; Winzer-Serhan,
2008; Cornelius and Day, 2009). Aside from the well documented
effects of maternal smoking to produce low birth weight, restricted
intrauterine growth, and increased incidence of sudden infant
death syndrome, it is also apparent that offspring are at increased
risk of developing substance use disorder. According to clinical
research, tobacco smoke-exposed offspring exhibit an increased
likelihood of drug abuse if they initiate drug taking behaviors
during adolescence (Kandel et al., 1994; Weissman et al., 1999;
Brennan et al., 2002; Buka et al., 2003).
Various animal models of prenatal nicotine (PN) exposure have
been used to elucidate the influence of nicotine on the neurobe-
havioral development of offspring (Dwyer et al., 2009; Heath and
Picciotto, 2009). In these models, PN is administered to rodents
either continuously via osmotic minipump (Slotkin et al., 1987;
Levin et al., 1996; Franke et al., 2007), orally, through drinking
water (Zhu et al., 1996; Pauly et al., 2004; Paz et al., 2007; Schneider
et al., 2010), or through intravenous (IV) injection (LeSage et al.,
2006; Harrod et al., 2011; Lacy et al., 2011). Multiple experiments
demonstrate that PN exposure alone produces alterations in the
neurodevelopment of the mesocorticolimbic dopamine (DA) sys-
tem, which in part mediates motivated behavior. Such PN-induced
changes are hypothesized to mediate alterations in the behavioral
repertoire of adolescent and adult offspring exposed to PN (Pauly
et al., 2004; LeSage et al., 2006; Franke et al., 2008; Lacy et al.,
2011). For example, experiments using the continuous route of
PN exposure resulted in decreased striatal DA content in weanling
rats (Richardson and Tizabi, 1994), increased c-fos expression in
the infralimbic cortex and nucleus accumbens core (Park et al.,
2006), and decreased nicotine-evoked DA release in the nucleus
accumbens shell of adolescent rats (Kane et al., 2004). In drug
self-administration experiments, adolescent offspring exposed to
continuous PN acquired cocaine self-administration at a higher
unit dose of drug relative to prenatal saline (PS) controls. This
finding suggests that PN exposure altered the reinforcing effects of
cocaine (Franke et al., 2008). Adult, PN-exposed female offspring
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self-administered a greater number of nicotine infusions than PS
rats following a period of forced abstinence, which suggests that
PN-exposed offspring exhibited increased motivation to respond
for nicotine (Levin et al., 2006). Together, these experiments indi-
cate that continuous PN exposure alters the neurodevelopment of
the mesocorticolimbic DA system and that such changes impact
the motivation for drug reward.
The present experiments determined if IV PN exposure altered
the motivational effects of the highly abused drug methamphet-
amine (METH) in adult offspring. It is of interest to use the
IV route of administration to deliver nicotine because it closely
models the nicotine pharmacokinetics of tobacco smoke inhala-
tion (Russell and Feyerabend, 1978; Mactutus, 1989; Booze et al.,
1999; Benowitz et al., 2009). The elimination half-life for nicotine
0.05 mg/kg/injection is approximately 50 min (Booze et al., 1999),
and so this method represents a unique exposure model in that the
dam and fetuses experience the bolus delivery of nicotine to the
brain followed by a rapid and precipitous clearance (Russell and
Feyerabend, 1978; Mactutus, 1989). Moreover, this method may
be used to deliver less overall daily amounts of nicotine relative
to other exposure models, while still providing a translationally
relevant exposure (see Dwyer et al., 2008). IV PN exposure pro-
duced changes in brain-derived neurotrophic factor throughout
the mesocorticolimbic DA system of adolescent offspring (Harrod
et al., 2011). Pre-weanling offspring exhibited hypoactive locomo-
tor activity in response to a novel context (LeSage et al., 2006),
and showed deficits in sensorimotor gating of the acoustic startle
response (Lacy et al., 2011). Furthermore, adult offspring showed
increased motivation for sucrose reward, relative to controls, when
rats responded according to a progressive-ratio schedule of rein-
forcement; and in this study there were no effects of prenatal treat-
ment when fixed-ratio (FR) schedules of reinforcement were used
(Lacy et al., 2012). These findings demonstrate that administration
of PN via the IV route produces changes in the neurodevelopment
of motivational brain systems, and that offspring exhibit behav-
ioral deficits during various stages of neurodevelopment, relative
to controls.
The present experiments tested the hypothesis that IV PN expo-
sure will result in offspring that exhibit altered sensitivity to the
rewarding and aversive effects of METH using two condition-
ing procedures: drug self-administration and conditioned taste
aversion (CTA). Previous research shows that PN-exposed off-
spring exhibited altered responding for IV nicotine (Levin et al.,
2006) and IV cocaine (Franke et al., 2008), according the drug
self-administration procedure. To date,no experiments have deter-
mined the effects of PN on the rewarding or aversive effects of
METH in offspring. Investigating METH is of interest because
amphetamines alter synaptic monoamine levels in the mesocor-
ticolimbic system differently than other abused drugs, such as
nicotine and cocaine. Amphetamines redistribute DA and other
monoamines from the presynaptic terminal to the synapse by
producing neurotransmitter release from vesicular monoamine
transporters; by inhibiting monoamine oxidase, and by reversing
DA transporter function (Sulzer et al., 2005). Cocaine and nicotine
increase synaptic DA levels by blockade of the DA transporter and
nicotinic receptor stimulated DA release, respectively (Laviolette
and van der Kooy, 2004; Gether et al., 2006).
Two separate experiments were therefore conducted to deter-
mine if PN offspring exhibit altered appetitive or aversive condi-
tioning to METH during adulthood. In experiment 1, PN animals
prenatally exposed to IV nicotine were trained to self-administer
METH (0.05 mg/kg/infusion) according to a FR schedule of rein-
forcement. Animals were then tested on multiple doses of IV
METH, ranging from 0.0005 to 1.0 mg/kg/infusion, to assess adult
offspring’s sensitivity to the reinforcing effects of the drug. Exper-
iment 2 determined if IV PN exposure alters acquisition and/or
extinction of METH-induced CTA, the standard method used
to assess the aversive effects of an unconditioned stimulus (US).
Potential differences in the sensitivity to the aversive effects of
METH were of interest because the trajectory for the escalation
of drug use may be determined, in part, by the relative response
to the aversive and rewarding effects of a drug (Davis and Riley,
2010). This is the first experiment to assess drug-induced CTA in
offspring of PN exposure. Adult offspring consumed a saccharin
conditional stimulus (CS), which was paired with the METH US
(0, 0.3, or 0.56 mg/kg; sc) to produce CTA learning, and extinction
of the conditioned response (CR) was measured, as well.
MATERIALS AND METHODS
ANIMALS
A total of 80 female and 30 male adult, nulliparous Sprague-
Dawley rats were acquired from Harlan Industries, Inc., (Indi-
anapolis, IN, USA). All rats were transported to the animal care
facilities in the psychology department at the University of South
Carolina and rodent food (ProLab Rat/Mouse/Hamster Chow
3000) and water were provided ad libitum throughout the course
of the experiments, except when otherwise specified. All ani-
mal cages were provided with Nylabones (Nylabone, Inc.; long
lasting durable chew-original; Neptune, NJ, USA) and Nestlets
(NestletsT; Ancare, Bellmore, NY, USA), for purposes of envi-
ronmental enrichment throughout the duration of the study. A
Nylabone was replaced if it was thoroughly chewed, and one Nest-
let nesting product was placed in the animals’ cage when the
cage was changed, which occurred 2×/week. The animal colony
was maintained at 21± 2˚C, 50± 10% relative humidity, and a
12L:12D cycle with lights on at 07:00 hours. The protocol for this
research methodology was approved by the Institutional Animal
Care and Use Committee (IACUC) at the University of South
Carolina.
BREEDING
Following a 7-day habituation period, female rats were housed
three per cage, and one male was placed with each triad from
approximately 17:00–09:00. Vaginal lavage samples were analyzed
daily with a microscope to determine if a sample was sperm-
positive. When a sample was identified as sperm-positive, the
corresponding female was single-caged and that day was consid-
ered gestational day (GD) 0. The weights of the pregnant dams
were recorded daily during pregnancy.
SURGERY: INDWELLING, INTERIORIZED JUGULAR CATHETERS
The internalized jugular catheters used in the present experiment
are commercially available from Harlan Industries. The catheter-
ization was performed at Harlan Industries (Indianapolis, IN,
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USA) according the methods of Mactutus et al. (1994) prior to
breeding. Briefly,animals were anesthetized with a mixture of keta-
mine hydrochloride (100 mg/kg/ml) and xylazine (3.3 mg/kg/ml).
Following anesthesia a sterile Intracath IV catheter (Becton, Dick-
inson and Co., Franklin Lakes, NJ, USA) with a Luer-Lok injection
cap (Medex, Inc., Carlsbad, CA, USA) was implanted dorsally
in a subcutaneous pouch. The distal end of the catheter was
inserted into the left jugular vein, advanced toward the heart,
and the catheter was bound with sterile suture. Animals were
kept under periodic post-operative observation and returned to
the colony upon recovery. On the day following surgery, catheters
were flushed with 0.2 ml of heparinized saline.
PN AND PS ADMINISTRATION
Pregnant dams were randomly assigned to either the PN
(0.05 mg/kg/ml) or PS groups. Nicotine or saline was adminis-
tered 3×/day via internalized IV catheters from GD 8–21. An
organism’s susceptibility to a teratogen can vary depending on
the stage of development (Vorhees, 1986). Implantation occurs
on approximately GD 6, and teratogens generally have an all-or-
none effect on the organism during the preimplantation phase of
development, which is considered to be approximately GD 1–7.
GD 8–21 was chosen as the period of IV nicotine administration
because this time includes the initial stages of neurogenesis and
migration, synaptogenesis, gliogenesis, and myelination. Thus, this
period represents a window of prenatal susceptibility for nico-
tine’s teratogenic effects on neural development (Dwyer et al.,
2008). Intravenous injections were delivered through the Luer-
Lok injection cap of the subcutaneously implanted injection port.
Following the first and second injections catheters were “post-
flushed” with 0.2 ml of 0.9% physiological saline because 0.2 ml
represents the approximate volume of the catheter. Post-flush of
0.2 ml of heparinized saline was used to flush the catheter and
to maintain catheter patency after the third, daily nicotine injec-
tion. All IV nicotine, saline, and post-flush injections were 20 s
in duration. All injections were performed during the light por-
tion of the photoperiod, and injections were administered daily at
approximately 1000, 1300, and 1600.
SURROGATE FOSTERING, LITTER COMPOSITION, AND POSTNATAL
TESTING
The day of birth was considered postnatal day (PND) 0. On PND
1 litters were culled to 10 with five males and five females when-
ever possible. All pups were surrogate-fostered to timed-pregnant,
drug naïve dams to prevent poor maternal care (Vorhees, 1986).
The developmental milestones of the righting reflex, negative geo-
taxis, and eye opening was assessed on PND 3–5, 8–10, and 13–17,
respectively. For each experiment, only one male and one female
randomly selected from each litter were assigned to each treatment
group (Holson and Pearce, 1992). The righting reflex was assessed
by placing animals on their backs; upon releasing the animals the
latency to right themselves to their stomachs was recorded. The
righting reflex was assessed in blocks of three trials across three
consecutive days with a maximum latency of 25 s per trial. Dur-
ing negative geotaxis testing animals were placed on a wire mesh
grid, positioned in a 25˚ downward angle. The latency (30 s maxi-
mum) for animals to turn 180˚ to face up the slope was recorded.
Negative geotaxis was measured in blocks of three trials across
three consecutive days. Each animal’s eyes (left and right) were
checked for degree of openness across five consecutive days. The
degree of openness was rated on a scale of 0–3: 0= completely
closed; 1= any opening exposing the cornea, regardless of how
small; 2= cornea and pupil are exposed but eye lids are not fully
open; 3= fully open. All animals’ weights were recorded on PND
1, 7, 14, and 21. Rats were weaned and pair housed, same sex, on
PND 21.
EXPERIMENT 1: METH SELF-ADMINISTRATION
APPARATUS
Operant chambers (ENV-008; Med-Associates, St. Albans, VT,
USA), housed within sound-attenuating enclosures, were con-
trolled by Med-PC computer interface software. The front and
back panels of the chamber were stainless steel and the sides and
top were constructed of polycarbonate. The front panel of the
chamber allowed access to a recessed food dipper (ENV-202M)
through a 5-cm× 5-cm opening. Two retractable metal levers
(ENV-112BM) on either side of the opening were located 7.3 cm
above a metal grid floor. A dipper equipped with a 0.1-ml cup
attached to the end of the dipper arm was raised into the food
receptacle, which allowed access to sucrose following the com-
pletion of a response requirement. A 28-V white cue light, 3 cm
in diameter, located above each response lever was used to sig-
nal time-outs. An infrared sensor (ENV-254-CB) was used to
detect head entries into the food receptacle. During drug self-
administration sessions a syringe pump (PHM-100) was used
to deliver intravenous infusions through a water-tight swivel
(PHM-115).
SUCROSE-MAINTAINED RESPONDING: PRELIMINARY TRAINING
Prenatal nicotine (n= 13 males; n= 9 females) and PS (n= 9
males; n= 7 females) offspring were food restricted in order to
maintain 85% of free-feeding weight for 3 days prior to the begin-
ning of dipper training. Dipper training and autoshaping were
conducted according to previous research (Reichel et al., 2008;
Lacy et al., 2012). Sucrose (26% w/v), was used as the reinforcer
during initial training sessions. Offspring were between 65 and
75 days of age at the beginning of preliminary training.
SUCROSE-MAINTAINED RESPONDING: FR TRAINING
Both levers were presented in the chamber, and rats learned to
respond for continuous reinforcement during 30-min sessions. A
response on the active lever resulted in 4 s of access to sucrose,
whereas responding on the inactive lever was recorded, but not
reinforced. After the first day on continuous reinforcement, food
was returned to the animal’s home cage allowing ad libitum access
for the remainder of the experiment. Animals were maintained
on the FR-1 schedule for 1 day and then transitioned to a FR-3
for 2 days. Stable responding was operationally defined as greater
than 2:1 ratio of active to inactive responses, and a minimum of
50 reinforcements by the second day of FR-3.
SURGERY: INDWELLING, EXTERIORIZED CATHETERS
Following acquisition of operant responding for sucrose reward
animals were allowed to free-feed for a minimum of 5 days before
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undergoing catheterization surgery. Animals were anesthetized
with ketamine (100 mg/kg/ml) and diazepam (5 mg/kg/ml) then
implanted with a catheter into the right jugular vein. The catheter
exited through a dental acrylic head mount. The head mounts are
secured to the skull with metal screws according to the methods of
Harrod et al. (2001). Animals were allowed to recover from surgery
for a minimum of 6 days during which time their catheters were
flushed with heparinized saline (0.2%). Animals were weighed
daily in order to monitor post-operative recovery.
METH SELF-ADMINISTRATION: FR TRAINING
During 60-min sessions, both the right and left levers were pre-
sented in the operant chamber. For FR-1 training each response on
the active lever resulted in a 5.9-s, intravenous infusion of METH
(0.05 mg/kg/infusion), which delivered approximately 0.1 ml of
solution. Responding on the inactive lever was recorded but not
reinforced. A 20-s signaled time-out, i.e., the illumination of both
cue lights, was initiated with the onset of the syringe pump. Ani-
mals were not reinforced for responding on either lever during the
signaled time-out. Animals were maintained on the FR-1 schedule
for a minimum of 5 days. Once stable responding was exhibited,
animals were transitioned to a FR-3 schedule of reinforcement.
Stable responding was operationally defined as less than 20% vari-
ability of active lever responding across two consecutive sessions,
greater than 2:1 ratio of active to inactive responses, and a mini-
mum of 10 reinforcements per session. Offspring were 95–105 days
old when METH self-administration began.
FR TESTING
After animals had displayed two consecutive days of stable
responding on a FR-3 schedule the rats began testing on
the same schedule for five different concentrations of METH.
The concentrations were 0.0005, 0.0025, 0.005, 0.025, and
0.1 mg/kg/infusion, which were presented according to a Latin-
square design. Animals returned to a FR-3 schedule and responded
for 0.05 mg/kg/infusion for a minimum of 1 day between each FR
testing session, and these were referred to as maintenance days. All
sessions were a maximum of 1 h in length.
EXPERIMENT 2: METH-INDUCED CTA
MATERIALS
During testing sessions animals received access to water or sucrose
via 100 ml graduated cylinders equipped with a #6.5 rubber stop-
per and 2.5′′ straight drinking tube on the home cage (OT-100;
Ancare, Bellmore, NY, USA). During the water recovery period
standard drinking bottles were used.
PROCEDURE
Acquisition
Conditioned taste aversion was assessed using 124 adult ani-
mals, 65 males, and 59 females. Offspring were between 92 and
114 days of age at the beginning of the experiment. Two doses
of METH (0.3 and 0.56 mg/kg/ml) were injected subcutaneously
(sc) as the US. Control animals were injected with saline (Sal; sc)
rather than METH. Animals were assigned to one of the follow-
ing six groups: PS-0.3 (male, n= 11; female, n= 9), PN-0.3 (male,
n= 11; female,n= 11), PS-0.56 (male,n= 11; female,n= 9), PN-
0.56 (male, n= 11; female, n= 11), PS-Sal (male, n= 10; female,
n= 9), PN-Sal (male, n= 11; female, n= 10). All rats received
water restriction for 4 days prior to conditioning. During water
restriction rats were given access to water for 15 min/day in 100 ml
graduated cylinders. Conditioning began on day 5. Animals were
presented with the saccharin (0.1% w/v) CS for 30 min, and were
then injected with either METH 0.3 or 0.56 mg/kg as the US or
Sal. On day 6, animals were given access to regular drinking water
in standard bottles for 30 min, and no injections were adminis-
tered following water consumption. This procedure was repeated
three times in total. Thus, rats were conditioned on days 5, 7, and
9, and water recovery days occurred on days 6, 8, and 10. CS-US
pairings occurred between 1400 and 1800. The dependent mea-
sure was the amount saccharin consumed on each of the three
conditioning days. Saccharin consumption was weight-corrected
[(ml consumed)/(body weight in grams)] because of the baseline
sex difference in body weight.
Extinction
Repeated exposure to the CS in the absence of the US will result in
a progressive attenuation of the CR. In order to generate extinc-
tion curves for the PS and PN rats, all animals were administered a
daily, two-bottle test on days 11–24. During two-bottle testing, the
bottles contained either water or saccharin, and the bottles were
placed on the cage in a balanced manner across groups. Animals
were given access to the bottles for 30 min. Preference scores were
derived by dividing the amount of saccharin consumed by the
combined amount of saccharin and water consumed. The scores
derived from this measure range from 0 to 1.0. Scores greater
than 0.5 indicate a preference for saccharin, and scores below 0.5
show a preference for water. Males and females from each prena-
tal treatment and drug treatment were represented during each
of the conditioning and testing sessions. Extinction tests occurred
between 1400 and 1800.
DRUGS
Nicotine hydrogen tartrate and METH hydrochloride were
acquired from Sigma-Aldrich Pharmaceuticals (St. Louis, MO,
USA). Nicotine (base weight) and METH (salt weight) were dis-
solved in physiological saline (0.9%; Hospira, Inc., Lake Forest,
IL, USA). The pH of the nicotine solution was neutralized to
approximately 7.0 with NaOH. Heparin (APP Pharmaceuticals,
Schaumburg, IL, USA) was added to saline and the heparinized
saline solution (2.5%) was used to flush the IV catheters.
DATA ANALYSIS
General: litter parameters
The between-subjects factors for the litter parameter analyzes were
Sex and Prenatal treatment (PN or PS). The within-subjects factors
were PND and GD. A one-way analysis of variance (ANOVA) was
conducted for the total number of pups born to PN and PS dams. A
Sex×Prenatal Treatment factorial ANOVA was used to analyze the
ratio of males to females born to PN and PS dams. A Sex×Prenatal
Treatment×PND mixed-factorial ANOVA was conducted for the
pup weight gain, righting reflex, negative geotaxis, and eye opening
data. A Prenatal Treatment×GD mixed-factorial ANOVA deter-
mined if there were differences between PS and PN dams on the
measure of maternal weight gain.
Frontiers in Pharmacology | Neuropharmacology June 2012 | Volume 3 | Article 116 | 4
Harrod et al. Prenatal nicotine increases METH sensitivity
Experiment 1: METH self-administration
The dependent measure for the METH self-administration study
was active lever presses. Analysis of the FR-3 testing data utilized
a 2× 2× 5 mixed-factorial ANOVA. The between-subjects fac-
tors were Prenatal Treatment and Sex, and the within-subjects
factor was Dose (METH dose; 0.0005, 0.0025, 0.005, 0.025,
0.1 mg/kg/infusion). The same factorial ANOVA was also con-
ducted on the inactive lever data. These analyses were considered
significant at p< 0.05.
Experiment 2: METH-induced CTA
The acquisition data were analyzed with a 2× 2× 3× 3 mixed-
factorial ANOVA. The between-subjects factors were Prenatal
Treatment, Sex, and Dose (0, 0.3, 0.56 mg/kg METH). The within-
subjects factor was Day, which represents the 3-days of condition-
ing trials. The dependent measure for the acquisition data was
saccharin consumption (ml/g). Because there was a significant
main effect of sex on the weight-corrected data, which indi-
cates that females consumed more saccharin relative to males,
the percent of control data were analyzed with a 2× 2× 3× 2
mixed-factorial ANOVA (the factor of dose was reduced to two)
in order to account for the baseline sex difference in saccharin
consumption.
A 2× 2× 3× 14 mixed-factorial ANOVA was used to ana-
lyze the two-bottle, extinction data. The between-subjects factors
were Prenatal Treatment, Sex, and Dose. The within-subjects fac-
tor was Day. For the extinction data, the dependent measure was
saccharin preference score [(saccharin)/(saccharin+water)]. Fol-
lowing a significant Dose×Day interaction, dependent t -tests
were conducted on days 1 and 14 of extinction to confirm if
animals in the SAL, METH 0.3, and METH 0.56 groups exhib-
ited a change in preference, i.e., extinction, from day 1 to day
14. Dunnett’s tests (Bonferroni correction), which compare treat-
ment groups to a single control, were conducted on day 14 data
to determine if the preference scores exhibited by the METH 0.3
and METH 0.56 groups differed from controls. These analyses
are important to determine if treatment groups exhibited full
or partial extinction. All analyzes were considered significant at
p< 0.05.
RESULTS
LITTER PARAMETERS
Data gathered from the PN and PS-exposed pups revealed no sig-
nificant effect of prenatal treatment on the number of pups born,
the ratio of male vs. female pups, righting reflex, negative geotaxis,
or eye opening (data not shown). Further, there was no signifi-
cant effect of Prenatal Treatment on dam weight gain (Figure 1A)
or pup weight gain (Figure 1B). These findings indicate that PN
exposure did not disrupt postnatal development according to the
ontogenetic measures used in the present study.
EXPERIMENT 1:METH SELF-ADMINISTRATION
A 2× 2× 5 mixed-factorial ANOVA revealed main effects of
Dose [F(1, 34)= 43.6, p< 0.001] and Prenatal Treatment [F(1,
34)= 4.3, p< 0.05], and a significant Dose×Prenatal Treat-
ment interaction [F(1, 34)= 4.9, p< 0.05]. Sex was not a sig-
nificant factor in the analyses. The METH self-administration
data are presented as two separate dose-response curves in
Figure 2. As can be seen in Figure 2, varying the unit dose
of IV METH produced the standard “U” shaped curve for the
PN and PS groups, which is commonly observed when animals
self-administer psychostimulant drugs, such as amphetamines
or cocaine (Yokel, 1987). Furthermore, the PS and PN groups
exhibited similar means of active lever presses when allowed
to respond for the lowest and highest unit doses of IV METH
tested. However, PS rats clearly showed peak responding at the
0.025-mg/kg/infusion dose, whereas the PN animals exhibited
peak responding between the 0.005- and 0.025-mg/kg/infusion
doses. The main effect of Prenatal Treatment indicates that PN
animals responded more for METH compared to the PS rats.
The significant Dose×Prenatal Treatment interaction indicates
that the PN dose-response curve shifted to the left. Analysis of
inactive lever responding revealed a significant effect of Dose
[F(1, 34)= 26.9, p< 0.001] and no other significant effects were
found. The means (±SEM) for inactive lever responding were
10.0 (±1.6), 8.9 (±1.3), 6.5 (±0.9), 5.0 (±0.8), and 3.9 (±0.6;
data not shown) for the 0.0005, 0.0025, 0.005, 0.025, and 1.0
doses, respectively. The main effect of dose shows that rats
responded more on the inactive lever when the dose was 0.0005
FIGURE 1 | (A) Mean (±SEM) weight gain data for the Saline and Nicotine dams across gestation. (B) Mean (±SEM) weight gain data for the PN and PS pups
across PND 1–21.
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and responding on this lever decreased as the unit dose of METH
increased.
These results indicate that the PN rats exhibited a leftward
shift in the dose-response curve relative to rats in the PS treat-
ment group. This indicates that PN rats were more sensitive to the
reinforcing effects of IV METH compared to the PS animals.
EXPERIMENT 2: METH-INDUCED CTA
Acquisition of CTA
A Sex×Prenatal Treatment×Dose×Day (2× 2× 3× 3) mixed-
factorial ANOVA was conducted on the weight-corrected data.
The analysis revealed a main effect of Sex: [F(1, 224)= 114.9,
p< 0.001], which indicates that females consumed more saccharin
relative to males. According to this analysis females consumed an
average of 0.06 ml/g of saccharin (SEM= 0.001), whereas males
consumed an average of 0.04 ml/g of saccharin (SEM= 0.001;
data not shown). Percent of control values were calculated, and
a Sex×Prenatal Treatment×Dose×Day (2× 2× 2× 3) mixed-
factorial ANOVA was conducted on these data in order to
adequately assess potential sex differences in CTA. The analy-
sis revealed no significant effects of Sex or Prenatal Treatment.
Figure 3 shows the acquisition curves (% of control) for PN
and PS groups injected with METH 0.3 or 0.56 mg/kg by condi-
tioning trials. The PN and PS groups represent both males and
females; however, the factors of Prenatal Treatment are repre-
sented on Figure 3 because prenatal treatment was the focus of the
experiment. The significant main effect of Day shows that animals
treated with the METH US exhibited decreased saccharin con-
sumption as a function of conditioning day [F(2, 152)= 484.8,
p< 0.001] and the main effect of Dose indicates that overall
the magnitude of CTA was greater in the METH 0.56 mg/kg
group [means (±SEM)= 0.667 (±0.018)], relative to the METH
FIGURE 2 | Mean (±SEM) active lever responses for the PS and PN
groups are presented for the METH doses 0.0005, 0.0025, 0.005, 0.025,
0.05, and 0.1mg/kg/injection according to a log10 scale. Data from the
training dose, 0.05 mg/kg/injection, is shown on the graph as a point of
reference, but was not included in the ANOVA. This point represents the
average responding for 0.05 mg/kg/infusion METH from the day before
testing with the 0.0005- to 0.1-mg/kg/infusion doses. PN animals showed a
leftward shift of the dose-response curve relative to the PS rats [Prenatal
Treatment×Dose interaction; F (1, 34)=4.9, p<0.05].
0.3 mg/kg group [0.798 (±0.018); F(1, 76)= 26.9, p< 0.001].
Moreover, repeated saccharin-METH pairings produced a pro-
gressive increase in the magnitude of CTA, and greater avoidance
behavior was observed from animals injected with the higher dose
of METH, according to the significant Day×Dose interaction
[F(2, 152)= 20.5, p< 0.001].
Extinction of CTA
A 2× 2× 3× 14 mixed-factorial ANOVA was conducted on the
extinction data. There were no significant main effects or inter-
actions with the factors of Sex or Prenatal Treatment. Figure 4
shows the saccharin preference data for the PN and PS groups
injected with SAL or METH 0.3 or 0.56 mg/kg US as a function
of extinction trials. The PN and PS groups represent both males
and females; however, the factors of Prenatal Treatment are repre-
sented on Figure 4 because prenatal treatment was the focus of the
study. Scores above 0.5 indicate a preference for saccharin, whereas
scores below 0.5 indicate a preference for water.
According to the significant main effect of Dose [F(2,
112)= 103.8,p< 0.001], different magnitudes of CTA were exhib-
ited by animals treated with SAL, METH 0.3, and METH
0.56 mg/kg. Thus, overall, rats treated with SAL or METH
0.3 mg/kg exhibited saccharin preference of 0.86 (±0.03) and
0.58 (±0.03), respectively; whereas the METH 0.56 mg/kg group
showed an overall water preference 0.29 (±0.03). The main effect
of Day [F(13, 1456)= 38.9, p< 0.001] shows that preference
scores changed following repeated, non-reinforced exposure to
the saccharin/water test stimuli; and the Day×Dose interaction
[F(26, 1456)= 7.5, p< 0.001] indicates that the preference scores
changed across testing days and was dependent on whether the
conditioning dose was 0.3 or 0.56 mg/kg.
In order to assess responding following repeated, non-
reinforced exposure to the CS, within-subjects comparisons
FIGURE 3 | Mean (±SEM) percent of control saccharin consumption
(ml/g) data from the acquisition phase of the experiment.The CS was
saccharin (0.1%, w/v) and the US was METH (SAL, 0.3 or 0.56 mg/kg). Data
are shown as percent of control for the PS and PN animals treated with
METH across conditioning days 1–3. There were no significant effects or
interactions with the factor of Prenatal Treatment or Sex.
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FIGURE 4 | Mean (±SEM) preference scores for the 14 consecutive
two-bottle extinction tests are presented for the PS and PN animals
that were treated with either SAL or 0.3mg/kg METH (A) or SAL or
0.56mg/kg METH (B). Scores above 0.5 indicate a preference for
saccharin and scores below 0.5 indicate a preference for water. There
were no significant effects or interactions with the factor of Prenatal
Treatment or Sex. Significant differences between days 1 and 14 are
indicated by * (p<0.001). Significant differences between SAL and the
0.3- and 0.56-mg/kg METH groups are indicated by ∧ (p<0.05) and ∧∧
(p<0.001).
between day 1 and 14 were conducted for the SAL, METH 0.3,
and METH 0.56 groups, as described by the Day×Dose inter-
action. Animals in the SAL group showed a consistent prefer-
ence for saccharin between testing days 1 and 14 [t (39)= 1.49,
p> 0.05]. Rats treated with METH 0.3 initially showed a prefer-
ence for water on day 1, and repeated exposure to the CS/water
resulted in extinction, which is represented as a saccharin prefer-
ence on day 14 [t (41)= 9.37, p< 0.001]. The change in respond-
ing represents a 91% increase in the preference score. Animals
in the METH 0.56 group exhibited a preference for water on
day 1, and despite a similar 91% increase in preference score,
these animals maintained an overall preference water on day 14
[t (41)= 4.62, p< 0.001; Figure 4]. Dunnette’s tests were con-
ducted for data from the three groups on day 14 to determine
if either the METH 0.3 or 0.56 groups were different than con-
trols on the final day of extinction training. The preference scores
from both the METH 0.3 and 0.56 groups were significantly lower
than the SAL group (p< 0.05 and p< 0.001, respectively). These
findings show that non-reinforced presentation of the CS pro-
duced extinction of the CR for both doses of the METH US
and 14 days of extinction did not fully extinguish the CR rela-
tive to the SAL controls. These data indicate that PN exposure
did not result in differential acquisition or extinction of METH-
induced CTA when rats were conditioned and tested during
adulthood.
DISCUSSION
The present experiments determined if IV PN exposure altered
the reinforcing and/or aversive effects of METH in adult offspring.
In experiment 1, PS and PN rats were trained to self-administer
METH according to a FR-3 schedule of reinforcement. Following
stable responding, rats were tested on varying doses of METH and
dose-response curves were generated for both groups. Although
both the PN and PS treatment groups exhibited the standard “U”-
shaped dose-response curve (Yokel, 1987), PN rats exhibited more
active lever responses for doses of METH, relative to controls. The
leftward shift in the PN rats’ dose-response curve, as indicated
by a significant main effect of prenatal treatment and a prenatal
treatment× dose interaction, indicates that these animals were
more sensitive to the reinforcing effects of METH compared to
rats in the PS group.
The enhanced sensitivity to IV METH exhibited by offspring
in the present study may be related to nicotine’s ability to induce
transcriptional activation of genes associated with drug reward
and sensitization of the mesocorticolimbic system (Zhu et al.,
2007; Levine et al., 2011). In a study by Levine et al. (2011), mice
were preexposed to oral nicotine or water and then were treated
with either saline or cocaine. Nicotine-treated mice exhibited
enhanced cocaine-induced locomotor sensitization and cocaine-
mediated conditioned place preference, and increased cocaine-
induced expression of accumbal FosB relative to controls that did
not receive nicotine treatment. The nicotine-mediated increase
in cocaine-induced FosB expression was associated with changes
in histone acetylation, suggesting an epigenetic explanation of
the findings (Levine et al., 2011). These and other findings sug-
gest that PN may modulate histone acetylation of FosB during
neurodevelopment, potentially leading to alterations in other tran-
scription factors, and D1 mediated signaling proteins (Teegarden
et al., 2008). Indeed, previous research demonstrates that PN alters
MAPk and PI3k signaling pathways (Wei et al., 2011) and increases
levels of mRNA and protein of brain-derived neurotrophic factor
throughout the mesocorticolimbic DA system (Harrod et al., 2011;
Wei et al., 2011). Thus, determining the effects of IV PN on histone
acetylation at FosB expression in offspring is of interest for future
investigation.
Adolescent offspring of continuous PN exposure were pre-
viously reported to exhibit altered responding for IV cocaine.
In that study Franke et al. (2008) investigated cocaine self-
administration using two different concentrations of the rein-
forcer, 200 or 500µg/kg/infusion, and focused on the acquisition
of FR-1 responding using adolescent offspring. These findings are
important because they demonstrate that rats treated with contin-
uous PN acquired self-administration at different concentrations
of cocaine: PN-treated rats acquired stable responding when the
concentration was 500, but not 200µg/kg/infusion, whereas the
opposite relationship was observed for controls. Thus, these data
show that PN rats required a concentration of cocaine that was
2.5 times higher than the dose needed for controls to acquire the
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response. Thus, the Franke et al. (2008) experiment suggests that
during the developmental period of adolescence, the PN animals
were less sensitive to the stimulus properties of IV cocaine than PS
offspring.
The present experiment focused on changes in the relative sen-
sitivity to IV METH after adult offspring acquired stable respond-
ing on a FR-3 schedule of reinforcement. Thus, offspring were
tested intermittently with various novel doses of the reinforcer
after maintenance of the CR was demonstrated. That adult PN
rats self-administered a lower dose of METH relative to controls
demonstrates that PN exposure alters the stimulus properties of
IV METH. Moreover, these effects of IV PN exposure appear to
endure, as offspring did not receive exposure to any drug between
birth and METH self-administration, which began during adult-
hood. This is an important point because nicotine exposure dur-
ing adulthood can alter gene expression and this can lead to an
altered response to other drugs of abuse, such as cocaine (Levine
et al., 2011). Further experiments need to determine if PS and
PN animals show differences in METH self-administration when
progressive-ratio schedules of reinforcement are used (Richardson
and Roberts, 1996). Such data will be necessary to determine if IV
PN exposure results in motivational differences for the reinforcing
effects of METH. Moreover, these findings suggest that PN expo-
sure may alter the function of various molecular targets for METH,
such as VMAT and DAT, through which this drug changes synap-
tic monoamine levels (Dwoskin and Crooks, 2002). Overall, PN
exposure alters the appetitive stimulus properties of psychostim-
ulant drugs like cocaine, nicotine, and METH, and these findings
suggest that such alterations in the reinforcing effects of abused
drugs could be one factor that underlies the increased vulnerability
to drug abuse that is documented in offspring of in utero tobacco
smoke exposure.
The aversive effects of abused drugs may play an important
role in offsetting the transition from recreational drug use to
chronic drug taking behavior (see Davis and Riley, 2010). Pre-
clinical research shows that nicotine exposure during early stages
of development (e.g., periadolescence) can alter learning about the
aversive effects of abused drugs in adulthood (Rinker et al., 2011).
Therefore it was also of interest to determine if PN exposure affects
the acquisition and expression of METH-induced CTA. Experi-
ment 2 showed that PN exposure did not alter METH-induced
CTA. PN and PS animals acquired CTA in a dose-dependent
manner and both treatment groups exhibited similar magnitudes
of conditioned responding, as measured by the acquisition and
extinction procedures. Thus, PN exposure did not alter the aversive
effects of METH when measured by the CTA procedure. Further
research needs to determine if a higher dose of IV PN will impact
the acquisition and expression of METH-induced CTA in off-
spring in order to fully determine if in utero nicotine exposure can
alter learning about the aversive effects of METH.
Low birth weight in offspring of maternal smoking is well doc-
umented (Ernst et al., 2001). These effects are produced, in part,
from nicotine, because PN exposure alone produces lower birth
weights in exposed rodent offspring relative to controls. This effect
has been observed in animal models using the continuous, IV, and
drinking water methods of nicotine exposure (e.g., Slotkin, 2004;
LeSage et al., 2006; Levin et al., 2006; Schneider et al., 2010), and in
general, the differences in weight are resolved with maturity. Low-
ering the dose of PN avoids birth weight deficits in offspring across
all of the abovementioned exposure models (e.g., Franke et al.,
2008; Schneider et al., 2010; Harrod et al., 2011), yet these studies
report neurochemical and behavioral alterations in the offspring.
The low dose, IV model of PN administration used in the present
experiment has not produced altered birth weight or weight gain
in offspring (Harrod et al., 2011; Lacy et al., 2011, 2012), according
to the described procedures. The current findings add to a growing
literature, which shows that PN exposure produces neurochemical
and behavioral changes in offspring born of normal birth weight
(Pauly et al., 2004; Franke et al., 2007, 2008; Schneider et al., 2010).
Taken together, the present findings indicate that IV PN expo-
sure altered the stimulus properties of METH when an appetitive
conditioning procedure was used. This finding adds to a growing
literature, which shows that IV PN can alter the behavior of off-
spring in later stages of development (LeSage et al., 2006; Harrod
et al., 2011; Lacy et al., 2011). An advantage to using the IV route of
administration is that IV injection allows for 100% bioavailability
of nicotine absorption and near instantaneous distribution. And,
as previously mentioned, the IV route of administration closely
mimics the pharmacokinetics of nicotine produced through cig-
arette smoke inhalation. Another advantage is that this exposure
method may be used to deliver less daily amounts of nicotine
relative to other exposure models (Russell and Feyerabend, 1978;
Mactutus, 1989; Booze et al., 1999; Benowitz et al., 2009). Lacy et al.
(2011) showed that the IV exposure method used in the present
study produced deficits in prepulse inhibition of the acoustic star-
tle response that are consistent with that induced by a continuous
GN exposure model (i.e., Popke et al., 1997), for example. There
are clearly disadvantages to all methods of PN exposure. A dis-
advantage of the present model may be that it requires direct
interaction with the dam in order to administer the daily prenatal
injections. On the other hand, this method affords a unique oppor-
tunity to monitor the animals’ progression through pregnancy
without adding what would otherwise be considered additional
stress. Another disadvantage is that the present model uses nico-
tine to mimic maternal smoking when there are approximately
4,000 active compounds in cigarette smoke.
The present experiments indicate that offspring of IV PN expo-
sure showed increased sensitivity to the reinforcing effects of the
highly abused drug METH. This finding suggests that women who
smoke a “low” number of daily cigarette during pregnancy may
alter the development of motivational systems in their offspring.
Increased sensitivity to the reinforcing properties of abused drugs
may be one important factor that mediates the increased vulner-
ability toward substance abuse in the offspring of women who
smoke tobacco throughout pregnancy.
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